Brief Report: Large‐scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus
Open Access
- 5 April 2012
- journal article
- systemic lupus-erythematosus
- Published by Wiley in Arthritis & Rheumatism
- Vol. 64 (9) , 2947-2952
Abstract
Objective: Systemic lupus erythematosus (SLE) disease manifestations are highly variable among patients, and the prevalence of individual clinical features differs significantly by ancestry. Serum tumor necrosis factor α (TNFα) levels are elevated in some SLE patients and may play a role in disease pathogenesis. The aim of this study was to look for associations between serum TNFα levels, clinical manifestations of SLE, autoantibodies, and serum interferon‐α (IFNα) levels in a large multiancestral SLE cohort.Methods: We studied serum TNFα levels in 653 SLE patients (214 African Americans, 298 European Americans, and 141 Hispanic Americans). TNFα was measured using an enzyme‐linked immunosorbent assay, and IFNα was measured with a functional reporter cell assay. Stratified and multivariate analyses were used to detect associations in each ancestral background separately, with meta‐analysis when appropriate.Results: Serum TNFα levels were significantly higher in SLE patients than in non–autoimmune disease controls (P < 5.0 × 10−3 for each ancestral background). High serum TNFα levels were positively correlated with high serum IFNα levels when tested in the same sample across all ancestral backgrounds (odds ratio range 1.76–1.86, P = 4.8 × 10−3 by Fisher's combined probability test). While serum TNFα levels alone did not differ significantly among SLE patients of different ancestral backgrounds, the proportion of patients with concurrently high levels of TNFα and IFNα was highest in African Americans and lowest in European Americans (P = 5.0 × 10−3). Serum TNFα levels were not associated with autoantibodies, clinical criteria for the diagnosis of SLE, or age at the time of sampling.Conclusion: Serum TNFα levels are high in many SLE patients, and we observed a positive correlation between serum TNFα and IFNα levels. These data support a role for TNFα in the pathogenesis of SLE across all ancestral backgrounds and suggest important cytokine subgroups within the disease.Keywords
This publication has 16 references indexed in Scilit:
- Interferon Alpha as a Primary Pathogenic Factor in Human LupusJournal of Interferon & Cytokine Research, 2011
- Network analysis of associations between serum interferon‐α activity, autoantibodies, and clinical features in systemic lupus erythematosusArthritis & Rheumatism, 2010
- Gene-Gene-Sex Interaction in Cytokine Gene Polymorphisms Revealed by Serum Interferon Alpha Phenotype in Juvenile DermatomyositisThe Journal of Pediatrics, 2010
- Toll-like receptors and innate immunityBiochemical and Biophysical Research Communications, 2009
- The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon‐α activity and low tumor necrosis factor α levels in patients with lupusArthritis & Rheumatism, 2008
- The role of tumor necrosis factor-alpha in systemic lupus erythematosusArthritis Research & Therapy, 2008
- Augmented interferon‐α pathway activation in patients with Sjögren's syndrome treated with etanerceptArthritis & Rheumatism, 2007
- High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosusGenes & Immunity, 2007
- Expression of interferon β in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritisAnnals of the Rheumatic Diseases, 2005
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982